Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine
by
Parke LA, Burton P, McDonald RV, Kim JA, Siegel S.
Department of Psychology,
Wilfrid Laurier University, Waterloo,
Ontario, Canada.
lparker@wlu.ca
Prog Neuropsychopharmacol Biol Psychiatry 2002 Feb;26(2):293-7


ABSTRACT

It has been reported that ibogaine interferes with somatic withdrawal reactions in rats chronically treated with morphine. The present experiments demonstrated that ibogaine also interferes with motivational withdrawal reactions and somatic withdrawal reactions in rats treated with morphine on only two occasions. On each of two conditioning trials, naloxone was administered 24 h following an injection of morphine. Four hours prior to each naloxone administration, rats were injected with either ibogaine or saline. In two experiments, ibogaine interfered with naloxone-precipitated withdrawal. In Experiment 1, ibogaine-treated rats displayed a weaker aversion to the withdrawal-paired chamber, and in Experiment 2, ibogaine-treated rats displayed fewer somatic withdrawal reactions than did saline treated rats.
Ibogaine
Morphine
Serotonin
Naloxone
Mescaline
Psychedelics
Cannabinoids
Benzodiazepines
Psychedelic honey
New drugs for addicts
MAOIs and hallucinogens
Nexus, cathinone, BDB, and MDA
Ibogaine signals addiction gene products
18-methoxycoronaridine (18-MC) and addiction


Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family